97.1%
DMT
…s Despite unclear efficacy and safety, many older pwMS continue DMT use. Use is primarily associated with relapsing-remitting MS, w…
8articles mentioning drugs
44drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: DMT ×
DMT
This drug is selected. Its supporting articles are shown below.
Articles mentioning DMT
8 articles · page 1 of 1DMTbreast cancermultiple sclerosisChemotherapy
…irmed disability progression (CDP) after cancer diagnosis, with DMT modelled as a time-varying covariate. Propensity score matching…
DMTrelapsing remitting multiple sclerosisRRMS
… or moderate-efficacy DMTs, an emulated a target trial compared DMT escalation within 6 months of a silent lesion versus unchanged …
glatiramer acetateDMTMultiple sclerosisMS
…y-six percent were on DMT at the time of relapse, most commonly glatiramer acetate. Average gestational age at birth was 39.3 weeks and 55% of par…
DMTDanish MS Registryrelapsing-remitting multiple sclerosis
…re 1.5 (IQR: 1.0–2.5) were included; 55 (34.0%) were exposed to DMT. 27 relapses were recorded (ARR (95% CI) 0.17 (0.11 to 0.26)) a…
ocrelizumabnatalizumabofatumumabrituximabmAb-BFDMTmultiple sclerosisneuromyelitis optica spectrum disorderGerman MS and Pregnancy Registrydisease-modifying therapy
…nfants, most were breastfed on natalizumab (n=125), followed by ocrelizumab (n=34), rituximab (n=11) and ofatumumab (n=10); three had multi…
CladribineDMTmultiple sclerosisRRMSUK
…Cladribine tablets, a highly effective (DMT), have been available in UK si…